Zoetis Non-US — Other increased by 150.0% to $4.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 150.0%, from -$8.00M to $4.00M.
Significant fluctuations may indicate changes in corporate cost allocation methodologies or one-time adjustments within international operations.
This metric captures residual assets, liabilities, or operational items within the non-US segment that do not fall into...
Comparable to 'Other' segment assets or liabilities reported by global peers in the animal health or pharmaceutical sectors.
zts_segment_non_us_other| Q1 '22 | Q1 '23 | Q1 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $3.00M | -$7.00M | $0.00 | -$8.00M | $4.00M |
| QoQ Change | — | -333.3% | +100.0% | — | +150.0% |
| YoY Change | — | -333.3% | +100.0% | — | +150.0% |